The trajectory of Sildenafil presents a challenging picture for those considering investment. While the initial release generated massive profits, the lapse of its patent opened the door to cheaper competitors, https://susanlast658707.imblogs.net/91675466/the-copyright-and-big-pharma-a-risky-investment